Litigation Details for Sanofi v. Alkem Laboratories Ltd (D. Del. 2015)
✉ Email this page to a colleague
Sanofi v. Alkem Laboratories Ltd (D. Del. 2015)
Docket | ⤷ Sign Up | Date Filed | 2015-12-22 |
Court | District Court, D. Delaware | Date Terminated | 2017-11-06 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 7,323,493; 8,318,800; 8,410,167; 9,107,900 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Sanofi v. Alkem Laboratories Ltd
Details for Sanofi v. Alkem Laboratories Ltd (D. Del. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2015-12-22 | 1 | Sanofi patents listed in the Orange Book for Multaq® tablets, including U.S. Patent No. 7,323,493 (“the…the ’493 patent”), U.S. Patent No. 8,318,800 (“the ’800 patent”), and U.S Patent No. 8,410,167 (“the ’…Certification”) with respect to the ’493 patent, the ’800 patent, and the ’167 patent. On information and… of its knowledge, the ’493 patent, the ’800 patent, and the ’167 patent are invalid and/or will not …alia, infringement of the ’493 patent, the ’800 patent, and the ’167 patent pursuant to 35 U.S.C. §271( | External link to document | |
2017-11-06 | 16 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,107,900 B2. (Attachments: #…2015 7 November 2017 1:15-cv-01200 830 Patent None District Court, D. Delaware | External link to document | |
2015-12-22 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,107,900 B2. (nmb) (Entered:…2015 7 November 2017 1:15-cv-01200 830 Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |